Achneck Hardean 4
4 · Aligos Therapeutics, Inc. · Filed Oct 10, 2024
Insider Transaction Report
Form 4
Achneck Hardean
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-08+75,000→ 75,000 totalExercise: $7.32Exp: 2034-10-08→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Twenty Five Percent (25%) of the shares subject to the option will vest on September 23, 2025 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.